21
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Stem cell patenting in Europe: the approaching climax*

Pages 103-112 | Published online: 03 Jan 2007
 

Abstract

A European patent application covering a culture of primate embryonic stem cells has been referred to the Enlarged Board of Appeal of the European Patent Office (EPO) after rejection by the Examining Division. These stem cells are derived directly from an embryo and so the case falls under the morality provisions of European Patent Convention (EPC) Article 53(a) and the interpretation of Rule 23d(c) of the EPC Regulations, which excludes the patenting of ‘uses of human embryos for industrial or commercial purposes’. The issues before the Enlarged Board are analysed and possible approaches to their resolution are offered. An opinion on the likely outcome of the Appeal is provided. Additional observations on non-moral issues are also offered.

Keywords::

Acknowledgements

*This is an expanded version of an article published in ‘BioScience Law Review’, the contents of which are reproduced here by kind permission.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,757.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.